Predictive Vulnerability Intelligence.

Product

  • Product
  • Pricing
  • Documentation

Company

  • About
  • Partnerships
  • Blog
  • Support

Legal

  • Terms
  • Privacy
  • Data Licensing

© 2026 FAUCET Technologies LLC. All rights reserved.

Nosegraze

First CVE: May 28, 2023Active for: 3 yearsTotal CVEs: 2

Nosegraze's vulnerability profile centers on its Novelist product, a web-based creative writing and manuscript management tool, with the observed weakness class centered on cross-site scripting vulnerabilities that reflect common input-handling challenges in web applications. Live severity, exploitation, and exposure counts are shown alongside this summary.

FAUCET AI Generated
2
Total CVEs
More Total CVEs than 56% of tracked vendors
1.0
Avg CVEs / Product / Year
More Avg CVEs / Product / Year than 12% of tracked vendors
5.1
Avg CVSS Score
Higher Avg CVSS Score than 14% of tracked vendors
0.0%
In CISA KEV
Bottom 1%

Trends Over Time

The number and severity of CVEs published that impact products developed by Nosegraze over time

Volume of CVEsAvg CVSS Base Score
First CVE
May 28, 2023
3 years ago
Most Recent CVE
Apr 15, 2024
833 days ago

Products(1 total)

Top CVEs

Signals from CVEs in this vendor scope (2 CVEs).

2 CVEs · Highest risk first

CVEPublishedCVSSRiskKEVExploit
CVE-2023-32958MEDIUM
Auth. (admin+) Stored Cross-Site Scripting (XSS) vulnerability in Nose Graze Novelist plugin <= 1.2.0 versions.
May 28, 20234.817NONO
CVE-2024-32093MEDIUM
Cross-Site Request Forgery (CSRF) vulnerability in Nose Graze Novelist.This issue affects Novelist: from n/a through 1.2.2.
Apr 15, 20245.415NONO
View all 2 CVEs →

CVE Severity & Scoring

Severity distribution of CVEs that affect this vendor's products2 CVEs
100%
Severity distribution among all CVEs352,727 CVEs
45%
40%
11%
Medium
Attack Vector
Local0 (0.0%)
Network2 (100.0%)
Unknown0 (0.0%)
Physical0 (0.0%)
Adjacent Network0 (0.0%)
Attack Complexity
Low2 (100.0%)
High0 (0.0%)
Unknown0 (0.0%)
User Interaction
None0 (0.0%)
Unknown0 (0.0%)
Required2 (100.0%)
Privileges Required
Low0 (0.0%)
High1 (50.0%)
None1 (50.0%)
Unknown0 (0.0%)

Exploit Exposure

Signals from CVEs in this vendor scope (2 CVEs).

CISA KEV
0 CVEs
0.0% of CVEs· Bottom 1%
Metasploit
0 CVEs
0.0% of CVEs· Bottom 1%
Nuclei
0 CVEs
0.0% of CVEs· Bottom 1%
ExploitDB
0 CVEs
0.0% of CVEs· Bottom 1%

Social Chatter

An overview of all social media posts that mention a CVE ID that affects a product developed by Nosegraze.

Media Mentions

Media articles that mention a CVE ID that affects a product developed by Nosegraze — matched by CVE ID, not by vendor name.

Top CNAs Publishing CVEs For Nosegraze's Products

View all 1 CNAs →

Top CWEs